The author of the study Michael B. Chancellor, M.D. and professor of urology and gynecology at the University of Pittsburgh School Medicine remarked that enlarged prostate is a challenging disease to live with because it causes difficult and frequent urination. Common treatments have some risks of serious collateral effects, such as impotence.

Up to one year post-injection, 73% of the study participants got a 30 percent improvement in urinary tract symptoms and qualify of life.

Botox reduces the size of the prostate gland through a cellular process called apoptosis, in which the prostate cells die in a programmed manner. This reduction of the prostate improves urine flow and decrease of urine left in the bladder.

Enlarged prostate is one of the most common diseases in men over the age of 60. Forty to fifty percent will develop symptoms as more frequent urination, urinary tract infections, the inability to completely empty the bladder and eventual damage to the bladder and kidneys.

Source: www.medicalnewstoday.com/medicalnews.php?newsid=71968&nfid=crss

This entry was posted on Tuesday, June 26th, 2007 at 9:56 am and is filed under Plastic Surgery News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.